Re: Darolutamide in nonmetastatic, castration-resistant prostate cancer

ARAMIS Investigators

doi:10.1056/NEJMoa1815671

Re: Darolutamide in nonmetastatic, castration-resistant prostate cancer

ARAMIS Investigators

Orion Corporation

Research output: Contribution to journal › Comment/debate/note

13 Citations (Scopus)

Original language	English
Pages (from-to)	660-661
Number of pages	2
Journal	Journal of Urology
Volume	202
Issue number	4
DOIs	https://doi.org/10.1056/NEJMoa1815671
Publication status	Published - Oct 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1056/NEJMoa1815671

Cite this

@article{8d241dfd287143729084a0f2d99d5a89,

title = "Re: Darolutamide in nonmetastatic, castration-resistant prostate cancer",

author = "\{ARAMIS Investigators\} and K. Fizazi and N. Shore and Tammela, \{T. L.\} and A. Ulys and E. Vjaters and S. Polyakov and M. Jievaltas and M. Luz and B. Alekseev and I. Kuss and C. Kappeler and A. Snapir and T. Sarapohja and Smith, \{M. R.\}",

year = "2019",

month = oct,

doi = "10.1056/NEJMoa1815671",

language = "English",

volume = "202",

pages = "660--661",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "4",

}

TY - JOUR

T1 - Re

T2 - Darolutamide in nonmetastatic, castration-resistant prostate cancer

AU - ARAMIS Investigators

AU - Fizazi, K.

AU - Shore, N.

AU - Tammela, T. L.

AU - Ulys, A.

AU - Vjaters, E.

AU - Polyakov, S.

AU - Jievaltas, M.

AU - Luz, M.

AU - Alekseev, B.

AU - Kuss, I.

AU - Kappeler, C.

AU - Snapir, A.

AU - Sarapohja, T.

AU - Smith, M. R.

PY - 2019/10

Y1 - 2019/10

UR - https://www.scopus.com/pages/publications/85095597745

U2 - 10.1056/NEJMoa1815671

DO - 10.1056/NEJMoa1815671

M3 - Comment/debate/note

C2 - 31294661

AN - SCOPUS:85095597745

SN - 0022-5347

VL - 202

SP - 660

EP - 661

JO - Journal of Urology

JF - Journal of Urology

IS - 4

ER -

Re: Darolutamide in nonmetastatic, castration-resistant prostate cancer

UN SDGs

Access to Document

Other files and links

Cite this